August 24, 2012 5:30 PM
|
by
Jocelyn Kaiser
Separate opinions may encourage plaintiffs to appeal
August 24, 2012 5:05 PM
|
by
Greg Miller
The anti-amyloid therapy solanezumab may slow cognitive decline in people with mild disease
August 24, 2012 10:58 AM
|
by
Jocelyn Kaiser
Ruling affirms lower court decision denying challenge to federal research on human embryonic stem cells
August 21, 2012 3:48 PM
|
by
Jocelyn Kaiser
Policy for researchers with more than $1 million in funding meant to squeeze more grants from flat budget
August 17, 2012 3:09 PM
|
by
Jon Cohen
Everyone born in the United States between 1945 and 1965 should be tested for this life-threatening virus, CDC says
August 16, 2012 2:15 PM
|
by
Eliot Marshall
Decision backs BRCA gene patents but rejects patents on testing
August 13, 2012 4:57 PM
|
by
Jocelyn Kaiser
Agency says it followed proper procedures in making award to Charles Nemeroff
August 10, 2012 3:50 PM
|
by
Jennifer Couzin-Frankel
Company’s decision is latest blow to once-promising strategy
by
Jon Cohen
H3N2 strain moves from pigs to kids
by
Greg Miller
Pfizer abandons development of the once-promising bapineuzumab
by
Jocelyn Kaiser
Scientists had expressed concern about charges of biased review
by
Jocelyn Kaiser
Posting investment reports online will hinder recruitment, some argue
by
John Bohannon
Study authors and bioethicists reject concerns that research subjects were unable to truly give informed consent
August 2, 2012 12:21 PM
|
by
Kai Kupferschmidt
Studies suggest starch derivatives may do more harm than good
August 1, 2012 11:01 AM
|
by
Angela Saini
State-of-the-art equipment to be reused for metabolomic studies
by
Eli Kintisch and David Malakoff
No end in sight for self-imposed ban
by
Jocelyn Kaiser
Ruling could spur crackdown on adult stem cell clinics
by
Leslie Roberts
Violence causes officials to halt eradication campaign in Karachi neighborhood
by
Jocelyn Kaiser
Plan retains random recruitment but not the original partner sites
by
Jocelyn Kaiser
Ban on economics research at NIH worries biomedical advocates
by
Jon Cohen
New report details progress and problems for HIV/AIDS issues
by
David Malakoff and Jocelyn Kaiser
But lawmakers chastise agency on Alzheimer's research funding
by
Jocelyn Kaiser
Agency posts details of how to apply to study 58 compounds
by
Gretchen Vogel
U.K. report examines ethics of in vitro fertilization methods
by
Jocelyn Kaiser
MD Anderson proposal will be evaluated by both business and research experts
by
Jocelyn Kaiser
Questions raised about conflicts of interest, university oversight
by
Jocelyn Kaiser
Charles Nemeroff is back in business
by
Eliot Marshall
U.S. health panel finds more harm than good in PSA screening
by
Jocelyn Kaiser
Contrary to scientists' views, MD Anderson drug discovery institute is "not a research program"
by
Jocelyn Kaiser
CPRIT comments on Alfred Gilman's plans to leave
by
Jocelyn Kaiser
Al Gilman cites concerns about peer review in resignation letter
by
Greg Miller
A 25-year-old research associate may have contracted fatal meningococcal infection in the lab
by
Jocelyn Kaiser
Agency to fund $20 million in grants for exploring uses for 24 compounds
by
David Malakoff
Plan seeks to involve institutions in identifying studies that could be used for both good and harm
by
Jocelyn Kaiser
Database will hold gusher of data from NCI's tumor sequencing projects
by
David Malakoff
U.S. Senate hearing examines "dual-use" biological research
April 27, 2012 12:24 PM
|
by
Martin Enserink
Researcher gets license to “export” revised manuscript
by
David Malakoff
U.S. Senate hearing explores H5N1 debate
by
Jocelyn Kaiser
Scientists discuss how NIH should recruit 100,000 mothers and kids
by
Martin Enserink
Fouchier and colleagues agree to apply for export license—under protest